JOIN US
Liquid Biopsy in Advanced

Prostate Cancer: Stay Up to Date

When a liquid biopsy report identifies a targetable driver, treatment decisions are clear. When there is no driver identified, the next steps are more uncertain. Expert speakers will present their perspectives on liquid biopsy for treatment selection in prostate cancer and discuss emerging biomarker ctDNA tumor fraction reported on Foundation Medicine’s liquid biopsy test.